INOVIO to Participate in Upcoming Scientific and Investor Conferences

Rhea-AI Summary

INOVIO (NASDAQ: INO) announced participation in upcoming scientific and investor conferences. Management will take part in a fireside chat at the Jefferies Global Healthcare Conference in New York on June 4 at 8:45 AM ET and present a poster at the World Orphan Drug Congress in Boston on June 11 from 12:00–12:10 PM ET.

A replay of the Jefferies investor event will be available for 90 days, and management will also hold one-on-one meetings with investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

News Market Reaction – INO

+4.00%

+4.00% News Effect

On the day this news was published, INO gained 4.00%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences:

Jefferies Global Healthcare Conference (New York)
Date: Thursday, June 4
Time: 8:45 AM ET
Format: Fireside Chat
Webcast: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/adRiTkvKf4AnDsZYyXatz8 

World Orphan Drug Congress (Boston)
Poster Presentation: Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine Date: Thursday, June 11
Time: 12:00 – 12:10 PM ET

A replay of the investor event will be available for 90 days at the link above. Members of INOVIO's management team will also be conducting one-on-one meetings with investors during the investor conference.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, investor.relations@inovio.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-scientific-and-investor-conferences-302784250.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (NASDAQ: INO) present at the Jefferies Global Healthcare Conference 2026?

INOVIO will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, at 8:45 AM ET. According to INOVIO, a replay of this investor event will be available for 90 days after the session.

How can investors access the INOVIO (INO) Jefferies Global Healthcare Conference 2026 webcast?

Investors can access INOVIO’s Jefferies Global Healthcare Conference fireside chat via an online webcast link provided by the company. According to INOVIO, a replay of the investor event will remain available for 90 days following the conference appearance.

What is INOVIO presenting at the World Orphan Drug Congress 2026 in Boston?

INOVIO will deliver a poster presentation titled “Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine.” According to INOVIO, this session at the World Orphan Drug Congress is scheduled for Thursday, June 11, from 12:00 to 12:10 PM ET.

Will INOVIO management hold one-on-one investor meetings at the June 2026 Jefferies conference?

Yes, INOVIO management plans to conduct one-on-one meetings with investors during the Jefferies Global Healthcare Conference. According to INOVIO, these meetings will complement the scheduled fireside chat, giving investors additional opportunities to discuss the company’s DNA medicine programs.

Why is INOVIO (INO) participating in both Jefferies and World Orphan Drug Congress events in June 2026?

INOVIO is joining these June 2026 conferences to engage investors and highlight its DNA medicine research. According to INOVIO, activities include a Jefferies fireside chat, investor one-on-ones, and a World Orphan Drug Congress poster on rare disease protein replacement therapeutics.